Eur Rev Med Pharmacol Sci 2020; 24 (16): 8239-8239
DOI: 10.26355/eurrev_202008_22579

MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway

R.-J. Wei, C.-H. Zhang, W.-Z. Yang

Department of Urology Surgery, The First Central Hospital of Baoding, Baoding, Hebei, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway, by R.-J. Wei, C.-H. Zhang, W.-Z. Yang, published in Eur Rev Med Pharmacol Sci 2017; 21(22): 5034-5041–DOI: 10.26355/eurrev_201711_13813–PMID: 29228417” has been withdrawn.

 

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/13813

Free PDF Download

To cite this article

R.-J. Wei, C.-H. Zhang, W.-Z. Yang
MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 16
Pages: 8239-8239
DOI: 10.26355/eurrev_202008_22579